Icelandic Drugmaker Actavis Up for Sale Say Sources

LONDON, Jan 8 (Reuters) - Iceland's Actavis, one of the world's top makers of generic drugs, is to be offered for sale by its private-equity owners in an auction that could raise $6 billion or more, three people familiar with the situation said.